Eli Lilly (LLY)
(Real Time Quote from BATS)
$862.99 USD
+5.52 (0.64%)
Updated Jul 22, 2024 01:02 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 28% (181 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.20 | 2.10 | 9.99 |
Current Quarter Estimate | 2.66 | 37.64 | 61.00 |
Year Ago Quarter Estimate | 2.11 | 11.39 | 54.84 |
Next Quarter Estimate | 3.81 | 34.85 | 63.00 |
Next Year Estimate | 19.42 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 116.93 | -0.90 | 15.67 |
Next Year | 41.65 | 15.80 | 9.31 |
Last 5 Years | 3.60 | 2.90 | 8.10 |
Next 5 Years | 33.30 | 12.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 117.78 | 15.53 |
Price/Book (MRQ) | 63.19 | 6.15 |
Price/Cash Flow (MRFY) | 112.43 | 10.87 |
Dividend Yield | 0.61% | 2.39% |
Net Profit Margin (TTM) | 17.08% | NA |
Return on Equity (TTM) | 56.98% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.